| __timestamp | Arrowhead Pharmaceuticals, Inc. | Biogen Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 1893422000 |
| Thursday, January 1, 2015 | 57410147 | 2012800000 |
| Friday, January 1, 2016 | 41454452 | 1973300000 |
| Sunday, January 1, 2017 | 31690298 | 2253600000 |
| Monday, January 1, 2018 | 52968505 | 2597200000 |
| Tuesday, January 1, 2019 | 81048686 | 2280600000 |
| Wednesday, January 1, 2020 | 128874979 | 3990900000 |
| Friday, January 1, 2021 | 206342000 | 2501200000 |
| Saturday, January 1, 2022 | 297307000 | 2231100000 |
| Sunday, January 1, 2023 | 353188000 | 2702600000 |
| Monday, January 1, 2024 | 505870000 | 2041800000 |
Unlocking the unknown
In the ever-evolving world of biotechnology, research and development (R&D) spending is a critical indicator of innovation and future growth. Over the past decade, Biogen Inc. and Arrowhead Pharmaceuticals, Inc. have demonstrated contrasting trajectories in their R&D investments. Biogen, a stalwart in the industry, consistently allocated substantial resources, peaking in 2020 with a 110% increase from 2014. Meanwhile, Arrowhead Pharmaceuticals, a rising star, showcased a remarkable growth story, with R&D expenses surging by over 2,000% from 2014 to 2024. This stark contrast highlights the dynamic nature of the biotech sector, where established players and emerging companies adopt diverse strategies to drive innovation. Notably, the data for 2024 shows a gap for Biogen, indicating potential shifts in their strategic focus. As the biotech landscape continues to evolve, these R&D trends offer valuable insights into the future of medical breakthroughs.
"Biogen vs. Arrowhead: A Decade of R&D Investment Trends"
Research and Development Expenses Breakdown: Novo Nordisk A/S vs Arrowhead Pharmaceuticals, Inc.
Research and Development Investment: Alnylam Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc.
Biogen Inc. or Genmab A/S: Who Invests More in Innovation?
Comparing Innovation Spending: Biogen Inc. and Incyte Corporation
Biogen Inc. and Arrowhead Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Viatris Inc. vs Arrowhead Pharmaceuticals, Inc.
R&D Spending Showdown: Opthea Limited vs Arrowhead Pharmaceuticals, Inc.
Analyzing R&D Budgets: Veracyte, Inc. vs Arrowhead Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Bausch Health Companies Inc. and Arrowhead Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Arrowhead Pharmaceuticals, Inc. and Novavax, Inc.